Grace Therapeutics, Inc.

GRCE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 May 13, 2025 FORM 4
4 May 13, 2025 FORM 4
4 May 13, 2025 FORM 4
SCHEDULE 13G/A May 8, 2025
4 Apr 16, 2025 FORM 4
4 Apr 16, 2025 FORM 4
4 Apr 16, 2025 FORM 4
4 Apr 16, 2025 FORM 4
4 Apr 16, 2025 FORM 4
8-K Apr 9, 2025 8-K
EFFECT Mar 13, 2025
CORRESP Mar 12, 2025
UPLOAD Mar 11, 2025
S-3 Mar 10, 2025 S-3
8-K Mar 3, 2025 8-K
D Feb 25, 2025
10-Q/A Feb 19, 2025 10-Q/A
8-K Feb 13, 2025 8-K
10-Q Feb 13, 2025 10-Q
8-K Feb 10, 2025 8-K
SCHEDULE 13G/A Jan 29, 2025
SC 13G/A Nov 14, 2024 SC 13G/A
SC 13G/A Nov 14, 2024
8-K Nov 13, 2024 8-K
10-Q Nov 13, 2024 10-Q
← Newer Page 4 of 24 · 599 filings Older →